Cargando…
Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia
The purpose of this work was to investigate if in adolescents with hyperuricemia serum levels of asymmetric and symmetric dimethylarginine (ADMA, SDMA) are increased and if their levels correlate with serum uric acid (UA). Patients and Methods. The study group consisted of 58 hyperuricemic patients...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810106/ https://www.ncbi.nlm.nih.gov/pubmed/24223456 http://dx.doi.org/10.1155/2013/267697 |
_version_ | 1782288745975775232 |
---|---|
author | Tenderenda-Banasiuk, Edyta Wasilewska, Anna Taranta-Janusz, Katarzyna Korzeniecka-Kozerska, Agata |
author_facet | Tenderenda-Banasiuk, Edyta Wasilewska, Anna Taranta-Janusz, Katarzyna Korzeniecka-Kozerska, Agata |
author_sort | Tenderenda-Banasiuk, Edyta |
collection | PubMed |
description | The purpose of this work was to investigate if in adolescents with hyperuricemia serum levels of asymmetric and symmetric dimethylarginine (ADMA, SDMA) are increased and if their levels correlate with serum uric acid (UA). Patients and Methods. The study group consisted of 58 hyperuricemic patients aged median 16.15 Q1–Q3 (14–17). The reference group contained 27 healthy individuals with normal serum UA level. ADMA and SDMA were measured by immunoenzymatic ELISA commercial kits and expressed in μmol/L. Serum UA was measured by the colorimetric method. Results. In hyperuricemic patients serum ADMA values did not differ between two estimated groups (P > 0.05); however, SDMA was significantly higher than in reference group (P < 0.01). Serum ADMA and SDMA correlated positively with UA (r = 0.34, P < 0.01) (r = 0.31, P < 0.01) and hs-CRP (r = 0.20, P < 0.05) (r = 0.36, P < 0.01), respectively. Conclusion. We demonstrated increased SDMA but not ADMA levels in adolescents with hyperuricemia and their correlation with serum uric acid levels. However, at the moment it is difficult to answer the question if it is just coexistence of these factors or any mechanism linking uric acid and methylated arginines really exists. |
format | Online Article Text |
id | pubmed-3810106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-38101062013-11-10 Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia Tenderenda-Banasiuk, Edyta Wasilewska, Anna Taranta-Janusz, Katarzyna Korzeniecka-Kozerska, Agata Dis Markers Clinical Study The purpose of this work was to investigate if in adolescents with hyperuricemia serum levels of asymmetric and symmetric dimethylarginine (ADMA, SDMA) are increased and if their levels correlate with serum uric acid (UA). Patients and Methods. The study group consisted of 58 hyperuricemic patients aged median 16.15 Q1–Q3 (14–17). The reference group contained 27 healthy individuals with normal serum UA level. ADMA and SDMA were measured by immunoenzymatic ELISA commercial kits and expressed in μmol/L. Serum UA was measured by the colorimetric method. Results. In hyperuricemic patients serum ADMA values did not differ between two estimated groups (P > 0.05); however, SDMA was significantly higher than in reference group (P < 0.01). Serum ADMA and SDMA correlated positively with UA (r = 0.34, P < 0.01) (r = 0.31, P < 0.01) and hs-CRP (r = 0.20, P < 0.05) (r = 0.36, P < 0.01), respectively. Conclusion. We demonstrated increased SDMA but not ADMA levels in adolescents with hyperuricemia and their correlation with serum uric acid levels. However, at the moment it is difficult to answer the question if it is just coexistence of these factors or any mechanism linking uric acid and methylated arginines really exists. Hindawi Publishing Corporation 2013 2013-09-26 /pmc/articles/PMC3810106/ /pubmed/24223456 http://dx.doi.org/10.1155/2013/267697 Text en Copyright © 2013 Edyta Tenderenda-Banasiuk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Tenderenda-Banasiuk, Edyta Wasilewska, Anna Taranta-Janusz, Katarzyna Korzeniecka-Kozerska, Agata Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia |
title | Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia |
title_full | Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia |
title_fullStr | Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia |
title_full_unstemmed | Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia |
title_short | Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia |
title_sort | asymmetric and symmetric dimethylarginine in adolescents with hyperuricemia |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810106/ https://www.ncbi.nlm.nih.gov/pubmed/24223456 http://dx.doi.org/10.1155/2013/267697 |
work_keys_str_mv | AT tenderendabanasiukedyta asymmetricandsymmetricdimethylarginineinadolescentswithhyperuricemia AT wasilewskaanna asymmetricandsymmetricdimethylarginineinadolescentswithhyperuricemia AT tarantajanuszkatarzyna asymmetricandsymmetricdimethylarginineinadolescentswithhyperuricemia AT korzenieckakozerskaagata asymmetricandsymmetricdimethylarginineinadolescentswithhyperuricemia |